Hms Capital Management, LLC Edwards Lifesciences Corp Transaction History

Hms Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$86.5 - $128.27 $49,564 - $73,498	573 Added 24.68%	2,895 $275,000
Q2 2021 Jul 13, 2021	BUY	$83.84 - $104.76 $194,676 - $243,252	2,322 New	2,322 $240,000
Q4 2020 Jan 29, 2021	SELL	$71.69 - $91.23 $224,963 - $286,279	-3,138 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $180,560 - $241,469	3,138 New	3,138 $217,000
Q1 2020 Apr 27, 2020	SELL	$52.41 - $81.0 $54,820 - $84,726	-1,046 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$47.89 - $64.05 $62,927 - $84,161	-1,314 Reduced 55.68%	1,046 $200,000
Q2 2018 Aug 06, 2018	BUY	$42.45 - $51.3 $100,182 - $121,068	2,360 New	2,360 $344,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.